Barhemsys
| Chemical Name | amisulpride |
| Dosage Form | Injection (intravenous; 5 mg/2 mL, 10 mg/4 mL) |
| Drug Class | Dopamine-2 antagonists |
| System | Nervous |
| Company | Acacia Pharma |
| Approval Year | 2020 |
Indication
- Indicated in adults for prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class.
- Indicated in adults for treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.